Locations:
Search IconSearch
September 1, 2017/Cancer/News & Insight

Ghosts: The Importance of Remembering Patients

How do we process the gravity of what we do?

bolwell_650x450

In his regular column in Oncology Times, Cleveland Clinic Cancer Center Chair Brian Bolwell, MD, FACP, explores topics critical to leading cancer centers in today’s healthcare environment. This time, he gets personal:

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

I think those of us who chose oncology did so with open eyes. We knew that a lot of our patients would die of cancer. And we are ok with that. We can help them throughout their journey. We see many people who are at their best when things are at their worst. We are also in a field that is highly intellectual with a rapidly expanding knowledge base—no other field of medicine is exploding with new discoveries and new treatments to the extent cancer medicine is. The ability to offer new therapies based on immunology or genomics is energizing. But year after year of getting calls in the middle of the day that one of our patients has died—with other patients waiting, or other issues that need to be addressed, and no time to adequately process the news—takes its toll. And I wonder if that toll is cumulative.”

Read the full column here.

Photo Credit: ©Russell Lee

Advertisement

Related Articles

adverse events from immune checkpoint inhibitors
December 21, 2023/Cancer/News & Insight
Managing Hormone Dysfunction-Related Adverse Events of Immunotherapy for Breast Cancer Treatment

Timing and type of side effects differ greatly from chemotherapy

23-CNR-4274330-CQD-Hero-650×450
October 18, 2023/Cancer/News & Insight
Cleveland Clinic Lerner Research Institute to Host Head & Neck Cancer CME Symposium

Sessions explore treatment advances and multidisciplinary care

23-CNR-4210971-CQD-Hero-650×450 Dr Yu
October 9, 2023/Cancer/News & Insight
Pathway Cross-Talk Suggests New Approach to Glioblastoma Treatment

New research from Cleveland Clinic helps explain why these tumors are so refractory to treatment, and suggests new therapeutic avenues

23-CNR-4071967-CQD-Hero-650×450 scan for triple-negative breast cancer case study
September 19, 2023/Cancer/News & Insight
Patient With Stage 4 Triple-Negative Breast Cancer in Remission 10 Years After Initial Diagnosis

Combination of olaparib and carboplatin results in complete durable response for a patient with BRCA2 and “BRCAness” mutations

23-CNR-4140381-CQD-Hero-650×450 eye toxicities in cancer treatment
September 7, 2023/Cancer/News & Insight
Eye Toxicities More Prevalent Side Effect of Cancer Treatment Than Previously Understood

Early communication between oncologists and ophthalmologist warranted

23-CNR-4185077-CQD-Hero-650×450
August 31, 2023/Cancer/News & Insight
CME Program Takes Multidisciplinary Approach to Colorectal Cancer

Case-based course delves into latest treatment approaches

outreach to underserved communities
June 2, 2023/Cancer/News & Insight
Focus Groups Amplify the Voices of Black Congregants about Disparities in Clinical Trials

Long-term relationship building and engagement key to gaining community trust

Ad